Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1361200

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1361200

Global Sjogrens Syndrome Therapeutics Market 2023-2027

PUBLISHED:
PAGES: 156 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The sjogrens syndrome therapeutics market is forecasted to grow by USD 691.09 million during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the sjogrens syndrome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong drug pipeline for launching medicines, high prevalence and incidence of sjogren's syndrome, and initiatives and expected approvals of products.

Technavio's sjogrens syndrome therapeutics market is segmented as below:

Market Scope
Base Year2022
End Year2027
Series Year2023-2027
Growth MomentumAccelerate
YOY 20233.68%
CAGR4%
Incremental Value$287.68mn

By Application

  • Clinical
  • Hospital

By Type

  • Primary
  • Secondary

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing development of biologics as one of the prime reasons driving the sjogrens syndrome therapeutics market growth during the next few years. Also, increasing diagnostic tests and biomarkers and rising number of awareness programs will lead to sizable demand in the market.

The report on the sjogrens syndrome therapeutics market covers the following areas:

  • Sjogrens syndrome therapeutics market sizing
  • Sjogrens syndrome therapeutics market forecast
  • Sjogrens syndrome therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sjogrens syndrome therapeutics market vendors that include AbbVie Inc., ADVANZ PHARMA Corp., Biogen Inc., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Johnson and Johnson, MorphoSys AG, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., RemeGen Ltd., Resolve Therapeutics LLC, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and TearSolutions Inc.. Also, the sjogrens syndrome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70328

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global sjogrens syndrome therapeutics market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)
  • 4.2 Application Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
  • 4.3 Type Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

  • 6.1 Market segments
  • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
  • 6.2 Comparison by Application
  • Exhibit 32: Chart on Comparison by Application
  • Exhibit 33: Data Table on Comparison by Application
  • 6.3 Clinical - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)
  • 6.4 Hospital - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Application
  • Exhibit 42: Market opportunity by Application ($ million)
  • Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 44: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
  • 7.2 Comparison by Type
  • Exhibit 46: Chart on Comparison by Type
  • Exhibit 47: Data Table on Comparison by Type
  • 7.3 Primary - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Primary - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Primary - Year-over-year growth 2022-2027 (%)
  • 7.4 Secondary - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Type
  • Exhibit 56: Market opportunity by Type ($ million)
  • Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Japan - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027
  • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 ADVANZ PHARMA Corp.
  • Exhibit 107: ADVANZ PHARMA Corp. - Overview
  • Exhibit 108: ADVANZ PHARMA Corp. - Business segments
  • Exhibit 109: ADVANZ PHARMA Corp. - Key offerings
  • Exhibit 110: ADVANZ PHARMA Corp. - Segment focus
  • 12.4 Bristol Myers Squibb Co.
  • Exhibit 111: Bristol Myers Squibb Co. - Overview
  • Exhibit 112: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 113: Bristol Myers Squibb Co. - Key news
  • Exhibit 114: Bristol Myers Squibb Co. - Key offerings
  • 12.5 Daiichi Sankyo Co. Ltd.
  • Exhibit 115: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibit 116: Daiichi Sankyo Co. Ltd. - Product / Service
  • Exhibit 117: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibit 118: Daiichi Sankyo Co. Ltd. - Key offerings
  • 12.6 GlaxoSmithKline Plc
  • Exhibit 119: GlaxoSmithKline Plc - Overview
  • Exhibit 120: GlaxoSmithKline Plc - Business segments
  • Exhibit 121: GlaxoSmithKline Plc - Key news
  • Exhibit 122: GlaxoSmithKline Plc - Key offerings
  • Exhibit 123: GlaxoSmithKline Plc - Segment focus
  • 12.7 Hikma Pharmaceuticals Plc
  • Exhibit 124: Hikma Pharmaceuticals Plc - Overview
  • Exhibit 125: Hikma Pharmaceuticals Plc - Business segments
  • Exhibit 126: Hikma Pharmaceuticals Plc - Key offerings
  • Exhibit 127: Hikma Pharmaceuticals Plc - Segment focus
  • 12.8 Horizon Therapeutics Plc
  • Exhibit 128: Horizon Therapeutics Plc - Overview
  • Exhibit 129: Horizon Therapeutics Plc - Business segments
  • Exhibit 130: Horizon Therapeutics Plc - Key news
  • Exhibit 131: Horizon Therapeutics Plc - Key offerings
  • Exhibit 132: Horizon Therapeutics Plc - Segment focus
  • 12.9 Johnson and Johnson
  • Exhibit 133: Johnson and Johnson - Overview
  • Exhibit 134: Johnson and Johnson - Business segments
  • Exhibit 135: Johnson and Johnson - Key news
  • Exhibit 136: Johnson and Johnson - Key offerings
  • Exhibit 137: Johnson and Johnson - Segment focus
  • 12.10 MorphoSys AG
  • Exhibit 138: MorphoSys AG - Overview
  • Exhibit 139: MorphoSys AG - Product / Service
  • Exhibit 140: MorphoSys AG - Key offerings
  • 12.11 Novartis AG
  • Exhibit 141: Novartis AG - Overview
  • Exhibit 142: Novartis AG - Business segments
  • Exhibit 143: Novartis AG - Key offerings
  • Exhibit 144: Novartis AG - Segment focus
  • 12.12 Otsuka Holdings Co. Ltd.
  • Exhibit 145: Otsuka Holdings Co. Ltd. - Overview
  • Exhibit 146: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibit 147: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibit 148: Otsuka Holdings Co. Ltd. - Segment focus
  • 12.13 RemeGen Ltd.
  • Exhibit 149: RemeGen Ltd. - Overview
  • Exhibit 150: RemeGen Ltd. - Product / Service
  • Exhibit 151: RemeGen Ltd. - Key offerings
  • 12.14 Resolve Therapeutics LLC
  • Exhibit 152: Resolve Therapeutics LLC - Overview
  • Exhibit 153: Resolve Therapeutics LLC - Product / Service
  • Exhibit 154: Resolve Therapeutics LLC - Key offerings
  • 12.15 TearSolutions Inc.
  • Exhibit 155: TearSolutions Inc. - Overview
  • Exhibit 156: TearSolutions Inc. - Product / Service
  • Exhibit 157: TearSolutions Inc. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 158: Inclusions checklist
  • Exhibit 159: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 160: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 161: Research methodology
  • Exhibit 162: Validation techniques employed for market sizing
  • Exhibit 163: Information sources
  • 13.5 List of abbreviations
  • Exhibit 164: List of abbreviations
Product Code: IRTNTR70328

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Application - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Application - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Application
  • Exhibits33: Data Table on Comparison by Application
  • Exhibits34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Application ($ million)
  • Exhibits43: Data Table on Market opportunity by Application ($ million)
  • Exhibits44: Chart on Type - Market share 2022-2027 (%)
  • Exhibits45: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by Type
  • Exhibits47: Data Table on Comparison by Type
  • Exhibits48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
  • Exhibits50: Chart on Primary - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on Primary - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Market opportunity by Type ($ million)
  • Exhibits57: Data Table on Market opportunity by Type ($ million)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Market opportunity By Geographical Landscape ($ million)
  • Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits101: Impact of drivers and challenges in 2022 and 2027
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: ADVANZ PHARMA Corp. - Overview
  • Exhibits108: ADVANZ PHARMA Corp. - Business segments
  • Exhibits109: ADVANZ PHARMA Corp. - Key offerings
  • Exhibits110: ADVANZ PHARMA Corp. - Segment focus
  • Exhibits111: Bristol Myers Squibb Co. - Overview
  • Exhibits112: Bristol Myers Squibb Co. - Product / Service
  • Exhibits113: Bristol Myers Squibb Co. - Key news
  • Exhibits114: Bristol Myers Squibb Co. - Key offerings
  • Exhibits115: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits116: Daiichi Sankyo Co. Ltd. - Product / Service
  • Exhibits117: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibits118: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits119: GlaxoSmithKline Plc - Overview
  • Exhibits120: GlaxoSmithKline Plc - Business segments
  • Exhibits121: GlaxoSmithKline Plc - Key news
  • Exhibits122: GlaxoSmithKline Plc - Key offerings
  • Exhibits123: GlaxoSmithKline Plc - Segment focus
  • Exhibits124: Hikma Pharmaceuticals Plc - Overview
  • Exhibits125: Hikma Pharmaceuticals Plc - Business segments
  • Exhibits126: Hikma Pharmaceuticals Plc - Key offerings
  • Exhibits127: Hikma Pharmaceuticals Plc - Segment focus
  • Exhibits128: Horizon Therapeutics Plc - Overview
  • Exhibits129: Horizon Therapeutics Plc - Business segments
  • Exhibits130: Horizon Therapeutics Plc - Key news
  • Exhibits131: Horizon Therapeutics Plc - Key offerings
  • Exhibits132: Horizon Therapeutics Plc - Segment focus
  • Exhibits133: Johnson and Johnson - Overview
  • Exhibits134: Johnson and Johnson - Business segments
  • Exhibits135: Johnson and Johnson - Key news
  • Exhibits136: Johnson and Johnson - Key offerings
  • Exhibits137: Johnson and Johnson - Segment focus
  • Exhibits138: MorphoSys AG - Overview
  • Exhibits139: MorphoSys AG - Product / Service
  • Exhibits140: MorphoSys AG - Key offerings
  • Exhibits141: Novartis AG - Overview
  • Exhibits142: Novartis AG - Business segments
  • Exhibits143: Novartis AG - Key offerings
  • Exhibits144: Novartis AG - Segment focus
  • Exhibits145: Otsuka Holdings Co. Ltd. - Overview
  • Exhibits146: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibits147: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibits148: Otsuka Holdings Co. Ltd. - Segment focus
  • Exhibits149: RemeGen Ltd. - Overview
  • Exhibits150: RemeGen Ltd. - Product / Service
  • Exhibits151: RemeGen Ltd. - Key offerings
  • Exhibits152: Resolve Therapeutics LLC - Overview
  • Exhibits153: Resolve Therapeutics LLC - Product / Service
  • Exhibits154: Resolve Therapeutics LLC - Key offerings
  • Exhibits155: TearSolutions Inc. - Overview
  • Exhibits156: TearSolutions Inc. - Product / Service
  • Exhibits157: TearSolutions Inc. - Key offerings
  • Exhibits158: Inclusions checklist
  • Exhibits159: Exclusions checklist
  • Exhibits160: Currency conversion rates for US$
  • Exhibits161: Research methodology
  • Exhibits162: Validation techniques employed for market sizing
  • Exhibits163: Information sources
  • Exhibits164: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!